| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | KARSEN PERRY A | Director | Dec 17, 2020 | Option Exercise | $36.00 | 177,528 | 6,391,522 | 93,764 | Dec 18, 2020, 04:29 PM | |
| OMED | OncoMed Pharmaceuticals Inc | KARSEN PERRY A | Director | Jun 05, 2017 | Buy | $3.46 | 10,000 | 34,588 | 10,000 | Jun 07, 2017, 06:18 PM | |
| NTLA | Intellia Therapeutics, Inc. | KARSEN PERRY A | Director | Jun 01, 2017 | Option Exercise | $11.98 | 5,000 | 59,925 | 5,000 | Jun 05, 2017, 08:01 AM | |
| JNCE | Jounce Therapeutics, Inc. | KARSEN PERRY A | Director | Feb 01, 2017 | Buy | $16.00 | 5,000 | 80,000 | 5,000 | Feb 02, 2017, 05:03 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Dec 17, 2015 | Option Exercise | $112.17 | 3,888 | 436,117 | 66,432 | Dec 18, 2015, 04:21 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | KARSEN PERRY A | Director | Jul 16, 2015 | Option Exercise | $0.01000 | 22,000 | 220 | 37,528 | Jul 21, 2015, 01:27 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | May 13, 2013 | Sale | $115.00 | 47,173 | 5,424,895 | 62,820 | May 15, 2015, 04:29 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | May 13, 2015 | Option Exercise | $48.94 | 30,470 | 1,491,296 | 109,993 | May 15, 2015, 04:29 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Apr 30, 2015 | Option Exercise | $108.06 | 5,807 | 627,504 | 79,523 | May 04, 2015, 07:15 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Mar 01, 2015 | Option Exercise | $121.53 | 4,321 | 525,131 | 74,130 | Mar 03, 2015, 04:24 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Feb 11, 2015 | Option Exercise | $78.82 | 55,792 | 4,397,248 | 98,013 | Feb 13, 2015, 05:07 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Feb 06, 2015 | Option Exercise | $118.75 | 15,758 | 1,871,263 | 70,117 | Feb 10, 2015, 06:49 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | KARSEN PERRY A | Director | Feb 05, 2015 | Option Exercise | $1.89 | 7,276 | 13,752 | 37,528 | Feb 09, 2015, 12:42 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Dec 30, 2014 | Sale | $67.57 | 42,607 | 2,879,167 | 74,744 | Jan 02, 2015, 04:01 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Nov 12, 2014 | Option Exercise | $73.89 | 71,494 | 5,282,398 | 90,830 | Nov 14, 2014, 04:13 PM | |
| NAVB | NAVIDEA BIOPHARMACEUTICALS, INC. | KARSEN PERRY A | Director | Nov 10, 2014 | Option Exercise | $1.32 | 10,252 | 13,533 | 30,252 | Nov 12, 2014, 11:17 AM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Aug 04, 2014 | Option Exercise | $55.30 | 85,554 | 4,731,466 | 97,860 | Aug 05, 2014, 04:14 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | May 01, 2014 | Sale | $103.61 | 94,356 | 9,776,391 | 37,627 | May 05, 2014, 06:16 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Mar 03, 2014 | Sale | $159.05 | 2,408 | 382,992 | 25,960 | Mar 05, 2014, 04:20 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Feb 12, 2014 | Option Exercise | $160.54 | 7,874 | 1,264,092 | 28,368 | Feb 14, 2014, 04:56 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Dec 27, 2013 | Option Exercise | $168.93 | 4,032 | 681,126 | 21,054 | Dec 31, 2013, 04:26 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Nov 01, 2013 | Option Exercise | $151.30 | 5,185 | 784,516 | 17,309 | Nov 05, 2013, 04:02 PM | |
| CELG | CELGENE CORP /DE/ | KARSEN PERRY A | see remarks | Aug 02, 2013 | Sale | $104.78 | 198,978 | 20,848,032 | 105,502 | Aug 02, 2013, 05:46 PM |
Menu